Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4925 |  HCWB HCW Biologics Inc. - Common Stock | 1.53 USD | -1.92% | -7.83% | -36.51% | +146.77% | 2.81 M USD | ||
| 4928 |  MTNB Matinas Biopharma Holdings, Inc. Common Stock | 2.79 USD | +2.57% | +8.14% | +1450.00% | +350.00% | 2.73 M USD | ||
| 4931 |  CLDI Calidi Biotherapeutics, Inc. Common Stock | 1.04 USD | +1.96% | -1.89% | -20.61% | +36.84% | 2.69 M USD | ||
| 4933 |  CANF Can-Fite Biopharma Ltd American Depositary Shares, each represe | 2.04 USD | -3.77% | -7.27% | -8.11% | -53.21% | 2.67 M USD | ||
| 4935 |  XRTX XORTX Therapeutics Inc. - Common Shares | 1.85 USD | +5.71% | +7.56% | -24.49% | +103.30% | 2.58 M USD | ||
| 4936 |  ONCO Onconetix, Inc. - Common Stock | 0.65 USD | +8.33% | -12.16% | -20.73% | -14.47% | 2.57 M USD | ||
| 4940 |  ELAB PMGC Holdings Inc. - Common Stock | 3.11 USD | -2.51% | -7.16% | -32.68% | +130.37% | 2.52 M USD | ||
| 4942 |  BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 USD | -15.62% | -15.25% | -32.98% | +9.88% | 2.41 M USD | ||
| 4948 |  SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 1.45 USD | +0.69% | -3.33% | -39.33% | +116.42% | 2.30 M USD | ||
| 4951 |  GNPX Genprex, Inc. - Common Stock | 2.75 USD | +4.96% | +7.42% | -18.64% | +47.06% | 2.25 M USD | ||
| 4960 |  OGEN Oragenics Inc. Common Stock | 0.48 USD | -4.00% | 0.00% | -5.88% | -23.81% | 2.17 M USD | ||
| 4963 |  GOVX GeoVax Labs, Inc. - Common Stock | 0.29 USD | 0.00% | -9.38% | -40.82% | -80.00% | 2.14 M USD | ||
| 4964 |  JUNS Jupiter Neurosciences, Inc. - Common Stock | 2.77 USD | -2.46% | +9.06% | -12.06% | +385.96% | 2.13 M USD | ||
| 4970 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 0.78 USD | -7.14% | -13.33% | -48.68% | -70.79% | 1.98 M USD | ||
| 4982 |  ARTL Artelo Biosciences, Inc. - Common Stock | 3.37 USD | -1.17% | -12.47% | -43.83% | +180.83% | 1.72 M USD | ||
| 4990 |  SPRC SciSparc Ltd. - Ordinary Shares | 4.43 USD | -4.53% | -3.06% | -8.28% | +0.68% | 1.62 M USD | ||
| 4991 |  JAGX Jaguar Health, Inc. - Common Stock | 4.53 USD | -9.40% | +8.89% | +1124.32% | +630.65% | 1.56 M USD | ||
| 4993 |  CRIS Curis, Inc. - Common Stock | 0.71 USD | -4.05% | -12.35% | -41.32% | -56.17% | 1.48 M USD | ||
| 4998 |  IMMP Immutep Limited - American Depositary Shares | 3.84 USD | -6.57% | -14.48% | +966.67% | +85.51% | 1.40 M USD | ||
| 5000 |  PPBT Purple Biotech Ltd - American Depositary Shares | 1.44 USD | -1.37% | +1.41% | -22.16% | +148.28% | 1.34 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |